BioSpace News Archive

Cellix Biosciences Inc. today announced confirmation from the U.S. Food and Drug Administration (FDA) that the 505(b)(2) regulatory pathway is appropriate for development of CLX-106 for treatment of relapsing-remitting multiple sclerosis.

Nohla Therapeutics announced the second closing of its Series B financing, bringing the total amount raised in this round to $56 million.

Medpace Holdings, Inc. announced that it will report its second quarter 2018 financial results after the market close on Monday, July 30, 2018.

– Schedules Investor Day on August 14th –

Recent media coverage has turned the World Health Assembly Resolution on Infant and Young Child Feeding into a political debate about breastfeeding vs formula feeding, rather than the public health issue at hand: access to proper information and nutrition education for parents of children up to three years of age.

CathWorks announced the approval of a new CPT code 0523T for non-invasive, 3D FFRangio™ enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions.

New surfactant replacement offers a promising alternative to polysorbates for stabilizing proteins.

Steering Committee of 8 Neurovascular Physicians Developed to Advance Robotic Technology for Neurovascular Interventions and Acute Stroke Care.

Net sales of $88.3 million, an increase of 1.6% year over year

Medical device veteran joins as company approaches important regulatory and commercial milestones